腹壁ヘルニア治療の世界市場レポート 2025年

腹壁ヘルニア治療市場規模は、今後数年間で力強い成長が見込まれます。2029年にはCAGR7.2％で69億米ドルに成長します。予測期間の成長は、外来処置の需要増加、ヘルスケア支出の増加、政府イニシアチブの拡大、ヘルニア修復手術の需要増加、研究開発投資の増加に起因すると考えられます。この期間の主な動向としては、ヘルニア修復装置の発展、生体吸収性材料の使用、戦略的協働、ロボット支援手術装置の開発、遠隔モニタリング技術の採用などが挙げられます。

肥満の有病率の上昇が腹壁ヘルニア治療市場の成長に大きく寄与しています。肥満は体脂肪過多を特徴とする病態であり、腹壁に負担がかかるため腹腔ヘルニアのリスクが高まる。食生活の乱れ、座りがちなライフスタイル、遺伝的素因、運動不足などの要因が、世界の肥満率の上昇につながっています。腹壁ヘルニア治療は、腹部の負担を軽減し、ヘルニアの再発リスクを減らし、腹部全体の筋力を向上させることにより、肥満に伴う合併症の管理に重要な役割を果たします。世界保健機関（WHO）によると、2024年3月の時点で、世界の8人に1人が肥満と闘っており、その中には25億人の過体重の成人が含まれ、8億9,000万人が肥満と分類されています。さらに、5歳未満の子どものうち3,700万人が肥満と報告されています。このような肥満の蔓延は、腹壁ヘルニア治療の需要を促進すると予想されます。

ヘルニア治療における技術の進歩は、市場の成長をさらに後押ししています。各社は、手術結果と患者の回復を改善するために、腹腔鏡下および開腹ヘルニアメッシュ固定装置などの革新的なソリューションを開発しています。腹腔鏡下および開腹下ヘルニアメッシュ固定器具は、低侵襲（腹腔鏡下）または従来の開腹アプローチによるヘルニア修復手術の際にメッシュを固定します。LIQUIFIX FIX8は低侵襲のヘルニア修復手術用に設計されており、LIQUIFIX Precisionは大腿ヘルニアおよび鼠径ヘルニアの開腹手術用に最適化されています。FDA承認のこれらの器具は、組織を貫通することなくメッシュを固定するリキッドアンカーを利用することで、外傷を減らし合併症を最小限に抑えることができます。米国では年間120万件以上のヘルニア治療が行われていることを考えると、このような進歩はより安全で正確な治療の選択肢を提供するものです。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場- マクロ経済シナリオ金利、インフレ、地政学、新型コロナウイルス感染症の影響と回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界腹壁ヘルニア治療PESTEL分析（政治、社会、技術、環境、法的要因、促進要因と抑制要因）
• 最終用途産業の分析
• 世界の腹壁ヘルニア治療市場：成長率分析
• 世界の腹壁ヘルニア治療市場の実績：規模と成長, 2019-2024
• 世界の腹壁ヘルニア治療市場の予測：規模と成長, 2024-2029, 2034F
• 世界腹壁ヘルニア治療総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界の腹壁ヘルニア治療市場：タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 上腹壁（胃部）ヘルニア
• 臍ヘルニア
• 瘢痕ヘルニア
• 世界の腹壁ヘルニア治療市場診断別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 超音波
• コンピュータ断層撮影（CT）スキャン
• 磁気共鳴画像法（MRI）
• 世界の腹壁ヘルニア治療市場手術によって、実績と予測, 2019-2024, 2024-2029F, 2034F
• 開腹ヘルニア手術
• 腹腔鏡手術
• ロボットによるヘルニア手術
• 世界の腹壁ヘルニア治療市場：エンドユーザー別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 病院
• 外来手術センター
• クリニック
• 世界の腹壁ヘルニア治療市場、上腹壁（胃部）ヘルニアの分類（タイプ別）、実績と予測, 2019-2024, 2024-2029F, 2034F
• 小さな上腹部ヘルニア
• 大きな上腹部ヘルニア
• 世界の腹壁ヘルニア治療市場、臍ヘルニアの種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 先天性臍ヘルニア
• 後天性臍ヘルニア
• 世界の腹壁ヘルニア治療市場、瘢痕ヘルニアのサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 原発性切開ヘルニア
• 再発性切開ヘルニア

第7章 地域別・国別分析

• 世界の腹壁ヘルニア治療市場：地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 世界の腹壁ヘルニア治療市場：国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• 腹壁ヘルニア治療市場：競合情勢
• 腹壁ヘルニア治療市場：企業プロファイル
  • Johnson And Johnson Services Inc. Overview, Products and Services, Strategy and Financial Analysis
  • AbbVie Overview, Products and Services, Strategy and Financial Analysis
  • Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
  • Medtronic Plc Overview, Products and Services, Strategy and Financial Analysis
  • Becton, Dickinson and Company（BD）Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• Baxter International Inc.
• Braun Melsungen AG
• Zimmer Biomet
• Olympus Corporation
• W.L. Gore and Associates Inc
• STERIS Plc
• Cook Medical Inc.
• KARL STORZ
• Cooper University Health Care
• Molnlycke Health Care
• Integra LifeSciences Holdings
• ConMed Corporation
• Aesculap Inc
• Richard Wolf GmbH
• Ethicon Inc

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• 腹壁ヘルニア治療市場2029：新たな機会を提供する国
• 腹壁ヘルニア治療市場2029：新たな機会を提供するセグメント
• 腹壁ヘルニア治療市場2029：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

Ventral hernia treatment involves medical procedures and interventions to repair hernias occurring in the abdominal wall. Common approaches include robotic-assisted surgery, tension-free mesh repair, and laparoscopic intraperitoneal techniques. The goal of treatment is to reposition displaced tissues, reinforce the abdominal wall, and prevent recurrence, ultimately relieving pain, restoring normal function, and reducing complications such as bowel obstruction or strangulation.

The primary types of ventral hernia treatment include epigastric (stomach area) hernia, umbilical (belly button) hernia, and incisional hernia. An epigastric hernia occurs when fatty tissue pushes through a weakened area in the upper abdominal wall between the sternum and the belly button. Diagnosis is performed using ultrasound, computed tomography (CT) scans, and magnetic resonance imaging (MRI). Treatment options include various surgical procedures such as open hernia surgery, laparoscopic surgery, and robotic hernia surgery. These treatments are utilized in hospitals, ambulatory surgical centers, and clinics.

The ventral hernia treatment market research report is one of a series of new reports from The Business Research Company that provides ventral hernia treatment market statistics, including ventral hernia treatment industry global market size, regional shares, competitors with a ventral hernia treatment market share, detailed ventral hernia treatment market segments, market trends and opportunities, and any further data you may need to thrive in the ventral hernia treatment industry. This ventral hernia treatment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The ventral hernia treatment market size has grown strongly in recent years. It will grow from $4.87 billion in 2024 to $5.23 billion in 2025 at a compound annual growth rate (CAGR) of 7.5%. The growth in the historic period can be attributed to the rising prevalence of obesity, increased awareness of ventral hernias, a growing aging population, higher disposable income, and the increasing demand for minimally invasive surgical procedures.

The ventral hernia treatment market size is expected to see strong growth in the next few years. It will grow to $6.90 billion in 2029 at a compound annual growth rate (CAGR) of 7.2%. The growth in the forecast period can be attributed to the rising demand for outpatient procedures, increased healthcare spending, growing government initiatives, a higher demand for hernia repair surgeries, and increased investment in research and development. Key trends during this period include advancements in hernia repair devices, the use of bioabsorbable materials, strategic collaborations, the development of robotic-assisted surgery devices, and the adoption of remote monitoring technologies.

The rising prevalence of obesity is significantly contributing to the growth of the ventral hernia treatment market. Obesity, a condition characterized by excessive body fat, increases the risk of ventral hernias due to the added strain on the abdominal wall. Factors such as poor diet, sedentary lifestyle, genetic predisposition, and lack of physical activity have led to an increase in obesity rates worldwide. Ventral hernia treatment plays a crucial role in managing complications associated with obesity by alleviating abdominal strain, reducing hernia recurrence risk, and improving overall abdominal strength. According to the World Health Organization (WHO), as of March 2024, one in eight people globally were struggling with obesity, including 2.5 billion overweight adults, with 890 million classified as obese. Additionally, 37 million children under the age of five were reported to be overweight. This growing obesity epidemic is expected to drive demand for ventral hernia treatments.

Technological advancements in hernia treatment are further propelling market growth. Companies are developing innovative solutions, such as laparoscopic and open hernia mesh fixation devices, to improve surgical outcomes and patient recovery. Laparoscopic and open hernia mesh fixation devices secure mesh during hernia repair surgeries, either through minimally invasive (laparoscopic) or traditional open approaches. In March 2024, TELA Bio Inc. introduced LIQUIFIX FIX8 and LIQUIFIX Precision in the U.S. The LIQUIFIX FIX8 device is designed for minimally invasive hernia repairs, while LIQUIFIX Precision is optimized for open femoral and inguinal hernia procedures. These FDA-approved devices utilize liquid anchors to secure mesh without penetrating tissue, thereby reducing trauma and minimizing complications. Given that over 1.2 million hernia procedures are performed annually in the U.S., such advancements offer safer and more precise treatment options.

In August 2023, Steris plc acquired the surgical instrumentation assets of Becton, Dickinson, and Company to strengthen its healthcare portfolio. This acquisition expands Steris plc's offerings in the surgical instrumentation market, allowing it to provide advanced tools and technologies to hospitals and surgical centers. By integrating these assets, Steris enhances its ability to deliver comprehensive solutions in the medical device industry while supporting growth in the ventral hernia treatment market.

Major players in the ventral hernia treatment market are Johnson And Johnson Services Inc., AbbVie, Abbott Laboratories, Medtronic Plc, Becton, Dickinson and Company (BD), Baxter International Inc., Braun Melsungen AG, Zimmer Biomet, Olympus Corporation, W.L. Gore and Associates Inc, STERIS Plc, Cook Medical Inc., KARL STORZ, Cooper University Health Care, Molnlycke Health Care, Integra LifeSciences Holdings, ConMed Corporation, Aesculap Inc, Richard Wolf GmbH, Ethicon Inc, Tela Bio, Microline Surgical, Hernia Mesh S.R.L., Insightra Medical Inc, Advanced MedTech Solutions Pvt Ltd.

North America was the largest region in the ventral hernia treatment market in 2024. Europe is expected to be the fastest-growing region in the forecast period. The regions covered in ventral hernia treatment report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the ventral hernia treatment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The ventral hernia treatment market consists of revenues earned by entities by providing services such as surgical consultations, hernia repair surgeries, post-operative care, diagnostic imaging and others. The market value includes the value of related goods sold by the service provider or included within the service offering. The ventral hernia treatment market also includes sales of fixation devices, surgical instruments, wound care products, surgical sutures and staplers. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values and are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Ventral Hernia Treatment Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on ventral hernia treatment market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for ventral hernia treatment ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The ventral hernia treatment market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Type: Epigastric (Stomach Area) Hernia; Umbilical (Belly Button) Hernia; Incisional Hernia
• 2) By Diagnosis: Ultrasound; Computed Tomography (CT) Scan; Magnetic Resonance Imaging (MRI)
• 3) By Surgery: Open Hernia Surgery; Laparoscopic Surgery; Robotic Hernia Surgery
• 4) By End Users: Hospitals; Ambulatory Surgical Centres; Clinics
• Subsegments:
• 1) By Epigastric (Stomach Area) Hernia: Small Epigastric Hernia; Large Epigastric Hernia
• 2) By Umbilical (Belly Button) Hernia: Congenital Umbilical Hernia; Acquired Umbilical Hernia
• 3) By Incisional Hernia: Primary Incisional Hernia; Recurrent Incisional Hernia
• Companies Mentioned: Johnson And Johnson Services Inc.; AbbVie; Abbott Laboratories; Medtronic Plc; Becton, Dickinson and Company (BD)
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Ventral Hernia Treatment Market Characteristics

3. Ventral Hernia Treatment Market Trends And Strategies

4. Ventral Hernia Treatment Market - Macro Economic Scenario Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

5. Global Ventral Hernia Treatment Growth Analysis And Strategic Analysis Framework

• 5.1. Global Ventral Hernia Treatment PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Ventral Hernia Treatment Market Growth Rate Analysis
• 5.4. Global Ventral Hernia Treatment Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Ventral Hernia Treatment Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Ventral Hernia Treatment Total Addressable Market (TAM)

6. Ventral Hernia Treatment Market Segmentation

• 6.1. Global Ventral Hernia Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Epigastric (Stomach Area) Hernia
• Umbilical (Belly Button) Hernia
• Incisional Hernia
• 6.2. Global Ventral Hernia Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Ultrasound
• Computed Tomography (CT) Scan
• Magnetic Resonance Imaging (MRI)
• 6.3. Global Ventral Hernia Treatment Market, Segmentation By Surgery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Open Hernia Surgery
• Laparoscopic Surgery
• Robotic Hernia Surgery
• 6.4. Global Ventral Hernia Treatment Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospitals
• Ambulatory Surgical Centres
• Clinics
• 6.5. Global Ventral Hernia Treatment Market, Sub-Segmentation Of Epigastric (Stomach Area) Hernia, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Small Epigastric Hernia
• Large Epigastric Hernia
• 6.6. Global Ventral Hernia Treatment Market, Sub-Segmentation Of Umbilical (Belly Button) Hernia, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Congenital Umbilical Hernia
• Acquired Umbilical Hernia
• 6.7. Global Ventral Hernia Treatment Market, Sub-Segmentation Of Incisional Hernia, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Primary Incisional Hernia
• Recurrent Incisional Hernia

7. Ventral Hernia Treatment Market Regional And Country Analysis

• 7.1. Global Ventral Hernia Treatment Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Ventral Hernia Treatment Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Ventral Hernia Treatment Market

• 8.1. Asia-Pacific Ventral Hernia Treatment Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Ventral Hernia Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Ventral Hernia Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Ventral Hernia Treatment Market, Segmentation By Surgery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Ventral Hernia Treatment Market

• 9.1. China Ventral Hernia Treatment Market Overview
• 9.2. China Ventral Hernia Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Ventral Hernia Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Ventral Hernia Treatment Market, Segmentation By Surgery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Ventral Hernia Treatment Market

• 10.1. India Ventral Hernia Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Ventral Hernia Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Ventral Hernia Treatment Market, Segmentation By Surgery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Ventral Hernia Treatment Market

• 11.1. Japan Ventral Hernia Treatment Market Overview
• 11.2. Japan Ventral Hernia Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Ventral Hernia Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Ventral Hernia Treatment Market, Segmentation By Surgery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Ventral Hernia Treatment Market

• 12.1. Australia Ventral Hernia Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Ventral Hernia Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Ventral Hernia Treatment Market, Segmentation By Surgery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Ventral Hernia Treatment Market

• 13.1. Indonesia Ventral Hernia Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Ventral Hernia Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Ventral Hernia Treatment Market, Segmentation By Surgery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Ventral Hernia Treatment Market

• 14.1. South Korea Ventral Hernia Treatment Market Overview
• 14.2. South Korea Ventral Hernia Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Ventral Hernia Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Ventral Hernia Treatment Market, Segmentation By Surgery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Ventral Hernia Treatment Market

• 15.1. Western Europe Ventral Hernia Treatment Market Overview
• 15.2. Western Europe Ventral Hernia Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Ventral Hernia Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Ventral Hernia Treatment Market, Segmentation By Surgery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Ventral Hernia Treatment Market

• 16.1. UK Ventral Hernia Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Ventral Hernia Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Ventral Hernia Treatment Market, Segmentation By Surgery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Ventral Hernia Treatment Market

• 17.1. Germany Ventral Hernia Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Ventral Hernia Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Ventral Hernia Treatment Market, Segmentation By Surgery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Ventral Hernia Treatment Market

• 18.1. France Ventral Hernia Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Ventral Hernia Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Ventral Hernia Treatment Market, Segmentation By Surgery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Ventral Hernia Treatment Market

• 19.1. Italy Ventral Hernia Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Ventral Hernia Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Ventral Hernia Treatment Market, Segmentation By Surgery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Ventral Hernia Treatment Market

• 20.1. Spain Ventral Hernia Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Ventral Hernia Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Ventral Hernia Treatment Market, Segmentation By Surgery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Ventral Hernia Treatment Market

• 21.1. Eastern Europe Ventral Hernia Treatment Market Overview
• 21.2. Eastern Europe Ventral Hernia Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Ventral Hernia Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Ventral Hernia Treatment Market, Segmentation By Surgery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Ventral Hernia Treatment Market

• 22.1. Russia Ventral Hernia Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Ventral Hernia Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Ventral Hernia Treatment Market, Segmentation By Surgery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Ventral Hernia Treatment Market

• 23.1. North America Ventral Hernia Treatment Market Overview
• 23.2. North America Ventral Hernia Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Ventral Hernia Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Ventral Hernia Treatment Market, Segmentation By Surgery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Ventral Hernia Treatment Market

• 24.1. USA Ventral Hernia Treatment Market Overview
• 24.2. USA Ventral Hernia Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Ventral Hernia Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Ventral Hernia Treatment Market, Segmentation By Surgery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Ventral Hernia Treatment Market

• 25.1. Canada Ventral Hernia Treatment Market Overview
• 25.2. Canada Ventral Hernia Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Ventral Hernia Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Ventral Hernia Treatment Market, Segmentation By Surgery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Ventral Hernia Treatment Market

• 26.1. South America Ventral Hernia Treatment Market Overview
• 26.2. South America Ventral Hernia Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Ventral Hernia Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Ventral Hernia Treatment Market, Segmentation By Surgery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Ventral Hernia Treatment Market

• 27.1. Brazil Ventral Hernia Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Ventral Hernia Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Ventral Hernia Treatment Market, Segmentation By Surgery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Ventral Hernia Treatment Market

• 28.1. Middle East Ventral Hernia Treatment Market Overview
• 28.2. Middle East Ventral Hernia Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Ventral Hernia Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Ventral Hernia Treatment Market, Segmentation By Surgery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Ventral Hernia Treatment Market

• 29.1. Africa Ventral Hernia Treatment Market Overview
• 29.2. Africa Ventral Hernia Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Ventral Hernia Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Ventral Hernia Treatment Market, Segmentation By Surgery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Ventral Hernia Treatment Market Competitive Landscape And Company Profiles

• 30.1. Ventral Hernia Treatment Market Competitive Landscape
• 30.2. Ventral Hernia Treatment Market Company Profiles
  • 30.2.1. Johnson And Johnson Services Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. AbbVie Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Medtronic Plc Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Becton, Dickinson and Company (BD) Overview, Products and Services, Strategy and Financial Analysis

31. Ventral Hernia Treatment Market Other Major And Innovative Companies

• 31.1. Baxter International Inc.
• 31.2. Braun Melsungen AG
• 31.3. Zimmer Biomet
• 31.4. Olympus Corporation
• 31.5. W.L. Gore and Associates Inc
• 31.6. STERIS Plc
• 31.7. Cook Medical Inc.
• 31.8. KARL STORZ
• 31.9. Cooper University Health Care
• 31.10. Molnlycke Health Care
• 31.11. Integra LifeSciences Holdings
• 31.12. ConMed Corporation
• 31.13. Aesculap Inc
• 31.14. Richard Wolf GmbH
• 31.15. Ethicon Inc

32. Global Ventral Hernia Treatment Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Ventral Hernia Treatment Market

34. Recent Developments In The Ventral Hernia Treatment Market

35. Ventral Hernia Treatment Market High Potential Countries, Segments and Strategies

• 35.1 Ventral Hernia Treatment Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Ventral Hernia Treatment Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Ventral Hernia Treatment Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer